PT DOMAS AGROINTI PRIMA – Trademark Portfolio

Entity Type: 99

PT DOMAS AGROINTI PRIMA holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include KRIEFA, KRIEHOL, KRIERINE, and KRIESTER.

Jl. Raya Access Road INALUM Km. 15,

Desa Lalang-Kuala Tanjung, Kec. Medang Deras, Kab. Batu Bara, Sumatera Utara, Indonesia, Kabupaten Batu Bara Sumatera Utara 21258

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KRIEFA
KRIEFA
Registered 2024
KRIEHOL
KRIEHOL
Registered 2024
KRIERINE
KRIERINE
Registered 2024
KRIESTER
KRIESTER
Registered 2024

Trademark Classifications

PT DOMAS AGROINTI PRIMA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does PT DOMAS AGROINTI PRIMA have?

PT DOMAS AGROINTI PRIMA has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does PT DOMAS AGROINTI PRIMA file in?

PT DOMAS AGROINTI PRIMA files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are PT DOMAS AGROINTI PRIMA's most well-known trademarks?

PT DOMAS AGROINTI PRIMA's registered trademark portfolio includes well-known marks such as KRIEFA, KRIEHOL, KRIERINE, and KRIESTER. These are among 4 currently registered trademarks in the portfolio.

What is PT DOMAS AGROINTI PRIMA's trademark registration success rate?

PT DOMAS AGROINTI PRIMA has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.